Merrimack Pharmaceuticals IPO Research Information

Merrimack Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Merrimack Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Merrimack Pharmaceuticals	MACK - NASDAQ	$8.00-$10.00	$7.00	$7.00	14.3 million	3/29/2012
Underwriter(s): J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Cowen and Company, Oppenheimer & Co.
Industry: Health Care
Filing(s):

Merrimack Pharmaceuticals Quote & Chart - Click for current quote - MACK

About Merrimack Pharmaceuticals (adapted from Merrimack Pharmaceuticals prospectus):
They are a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with companion diagnostics.

This description is adapted from Merrimack prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Merrimack "MACK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.